|
Development of a novel algorithm to identify staging and lines of therapy for bladder cancer. |
|
|
Research Funding - Merck Sharp & Dohme |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Merck Sharp & Dohme |
Stock and Other Ownership Interests - Merck Sharp & Dohme |
Research Funding - Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Merck Sharp & Dohme |
|
|
No Relationships to Disclose |